Drugs / Hibiscus Sabdariffa

Trials 2 · a red edge is where a trial was stopped

2012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 31 trial
Phase 3 NCT01414374 Jan → Dec 2012 iron deficiency anemia Casa Espirita Terra de Ismael Completed No outcome recorded
Phase not applicable1 trial
NCT06413550 Apr 2024 → Jan 2025 radiation-induced disorder Ain Shams University Unknown No outcome recorded
Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
NCT02216253 Comparator Oct 2014 → Aug 2015 pelvic organ prolapse, urinary tract infection IRCCS San Raffaele Completed No outcome recorded

Evidence & citations 6 cited values

Every value below carries the sentence it was read from. 3 sources stand behind the page.

FieldValueCited text
Known as Hibiscus Sabdariffa Hibiscus sabdariffa (powdered dry plant), 200 mg, BID” NCT01414374
2

NCT02216253

NCT06413550

Known as Hibiscus Sabdariffa L. “The Efficacy of Hibiscus Sabdariffa L. Mouth Rinse in Head and Neck Cancer Patients With Xerostomia: A Randomized, Placebo-Controlled Clinical Trial” NCT06413550
Known as karkadé “Aqualief contains two key ingredients, carnosine and karkadé (Hibiscus sabdariffa), which were selected and mixed with normalizing saliva pH and increasing saliva buffering activity.” NCT06413550
Known as Roselle “The fresh red Roselle plant was obtained; the red calyxes of Hibiscus Sabdariffa were separated from the plant and dried for a week at 25°C.” NCT06413550
Modality Traditional medicine (herbal / TCM) “a composite herbal medicine (Hibiscus sabdariffa plus Centella asiatica)” NCT01414374
Route Oral “as oral rinse” NCT06413550